Phenylephrine Hydrochloride Injection
Product Images NDC 36000-360

This is a pharmaceutical product label for Phenylephrine, a medication used for intravenous use. The usual dosage information can be found in the package insert. The storage temperature recommended is between 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). The medication is in a 10 mg/mL concentration and should be stored in a cool and dry place until the time of use. It needs to be diluted before use and any unused portion should be discarded. The product is manufactured for Baxter Healthcare Corporation in the USA and is made in India.*

This text appears to be a label for a medical product called "Phenylephrine Hydrochloride Injection, USP" with a concentration of 10 mg/mL. It comes in 1 mL single-dose vials and is meant for intravenous use after dilution. Users are advised to discard any unused portion, protect it from light, and store it in the provided carton until needed. The manufacturer of this product is Baxter.*

This is a description of a medication solution containing phenylephrine hydrochloride, sodium chloride, sodium citrate dihydrate, citric acid monohydrate, and sodium metabisulfite in water for injection. It gives instructions for storage, mentions absence of natural rubber latex in vial stoppers, and provides pH adjustment details. The solution is to be stored within a temperature range of 20°C to 25°C with permissible excursions. The package insert contains directions for use.*

This text provides information about a medication labeled as NDC 36000-360-10, Phenylephrine Hydrochloride, intended for intravenous use. It mentions that the Pharmacy Bulk Vial should be used in a suitable area such as a laminar flow hood or clean air compounding area. It also states that the vial should be used within 4 hours after being penetrated. The storage instructions include keeping it at 20°C to 25°C, with excursions permitted to 15°C to 30°C. The text also specifies that the product is not for temperature-controlled room storage and should be kept in the carton until use. The medication is manufactured by Baxter Healthcare Corporation in India.*

This document provides information about a medication called Phenylephrine Hydrochloride Injection, USP. It contains 50 mg of Phenylephrine in 5 mL of solution, with a concentration of 10 mg/mL. The injectable is intended for intravenous use and is supplied as a Pharmacy Bulk Package consisting of 10 vials, each containing 5 mL. The medication must be diluted before administration, should be protected from light, and stored in the provided carton until it is ready for use. The brand associated with this product is Baxter.*

This is a medication description for a solution containing phenylephrine hydrochloride used for injection. It also includes other ingredients such as sodium chloride, sodium citrate, citric acid, and sodium metabisulfite. The pH of the solution can range from 3.5 to 5.5. The instructions for use can be found in the package insert. The vial should be stored at a temperature between 20°C to 25°C, with excursions permitted. The vial stoppers are not made with natural rubber latex. The product should be used in a suitable work area like a laminar flow hood. It is manufactured by Baxter Pharmaceuticals India Private Ltd for Baxter Healthcare Corporation based in Deerfield, IL, USA. The revision date is 2022-09-13.*

This text contains information about Phenylephrine Hydrochloride Injection, USP in a Pharmacy Bulk Package. It specifies that the product is for Intravenous Use and must be diluted. The vial is 100 mg/10 mL and should be protected from light. There are directions for use mentioned, and it should be stored between 20°C to 25°C. It also highlights that the Pharmacy Bulk Vial should only be used in a suitable work area. The product has an expiration date and is manufactured by Baxter Healthcare Corporation in the USA.*